EXEL Exelixis, Inc.

64.63USD-1.82%Mkt Cap: 15.77B USDP/E: 19.35

Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatme…